YOUNGSTOWN — Thursday was the first day of the Youngstown Health District’s vaccination clinic at the Covelli Centre, administering the one-shot Johnson & Johnson Janssen vaccine.

Erin Bishop, Youngstown health commissioner, said there is no concern about the vaccines being administered at the Covelli Centre because they are not affected by a manufacturing error of Johnson & Johnson vaccines at a Baltimore facility.

The error could affect up to 15 million doses of the vaccine, but it does not affect any Johnson & Johnson doses that are being delivered and used nationwide, the New York Times reported.

Doses being produced and shipped so far in the U.S. came from a plant in the Netherlands, the Times reported.

Bishop, who was working the clinic, said her only concern is that the mistake at the Baltimore facility could affect the amount of vaccine shipments coming from Johnson & Johnson.

But if the Johnson & Johnson vaccine were not available, she said, the Youngstown Health District can switch to the Moderna vaccine, which it has used in the past.

The clinic will operate every Thursday in April except April 15 because that clinic will be April 14. It also will have a clinic May 6.

Emergent BioSolutions, a little-known company vital to the vaccine supply chain, was a key to Johnson & Johnson’s plan to deliver 100 million doses of its vaccine to the United States by the end of May. But the Food and Drug Administration repeatedly has cited Emergent for problems such as poorly trained employees, cracked vials and problems managing mold and other contamination around one of its facilities, according to records obtained by The Associated Press through the Freedom of Information Act. The records cover inspections at Emergent facilities since 2017.

Johnson& Johnson said Wednesday that a batch of vaccine made by Emergent at its Baltimore factory, known as Bayview, cannot be used because it did not meet quality standards. It was unclear how many doses were involved or how the problem would affect future deliveries of J&J’s vaccine. The company said in a statement it still was planning to deliver 100 million doses by the end of June and was “aiming to deliver those doses by the end of May.”

The Associated Press contributed to this report.

news@tribtoday.com